Sclerosis multiplex (SM): vizsgálatok itt: Németország
14 of 39 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
- Where
- Aachen, Amberg, Arnsdorf, Aschaffenburg, Bad Soden, Bamberg, Berg, Berlin, Bochum, Bogen, Buchholz, Celle, Chemnitz, Cologne, Dortmund, Düsseldorf, Eltville, Erbach/Odenwald, Erlangen, Essen, Forchheim, Frankfurt, Freiburg im Breisgau, Füssen, Giessen, Gladenbach, Günzburg, Halle, Hamburg, Hanover, Hennigsdorf, Herford, Hettingen, Ibbenbueren, Isselburg, Jena, Kiel, Leipzig, Lübeck, Magdeburg, Mannheim, Marburg, Meerbusch, Minden, München, Münster, Neuburg am Inn, Neuruppin, Neu-Ulm, Nuremberg, Öhringen, Osnabrück, Pforzheim, Quakenbrück, Regensburg, Remscheid, Rülzheim, Schwetzingen, Siegen, Singen, Sinsheim, Steglitz, Stuttgart, Sundern, Tübingen, Ulm, Unterhaching, Weil der Stadt, Wolfratshausen, Zwickau
- Életkor
- 18 év and over
- People
- 842 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06780150 - No phaseCsak meghívásosMS-Related Disability Worsening and Thalamic Volume Loss
- Where
- Dresden, Multiple Locations
- Életkor
- 18 év to 55 év
- People
- 2400
- Run by
- Jung Diagnostics GmbH
See details and how to joinNCT07753928 - No phaseTaking peoplePregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- Where
- Bochum
- People
- 908 worldwide
- Run by
- Biogen
See details and how to joinNCT05658497 - No phaseTaking peopleA NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
- Where
- Aalen, Albstadt, Altenburg, Altenholz, Altmark, Alzey, Bad Homburg, Bamberg, Bayreuth, Bergneustadt, Berlin, Böblingen, Bochum, Bogen, Bonn, Braunschweig, Bremen, Chemnitz, Coburg, Cologne, Crailsheim, Dessau, Dillingen an der Donau, Dillingen Saar, Dortmund, Dresden, Duisburg, Düsseldorf, Eisleben Lutherstadt, Eltville, Erbach im Odenwald, Erfurt, Erlangen, Essen, Falkensee, Frankfurt am Main, Fulda, Gelsenkirchen, Giessen, Gladenbach, Görlitz, Hagen, Halle, Hamburg, Hanover, Hettingen, Höxter, Ingelheim, Itzehoe, Jena, Kaiserslautern, Karlsruhe, Leipzig, Lünen, Magdeburg, Mannheim, Marburg, Meerbusch, Merzig, Mettmann, Minden, Montabaur, Mühlhausen, Mülheim, München, Munich, Münster, Nagold, Neuburg A.d. Donau, Neuruppin, Nuremberg, Oer-Erkenschwick, Oldenburg, Osnabrück, Pforzheim, Potsdam, Regensburg, Remscheid, Rostock, Rüdersdorf, Rülzheim, Saarlouis, Salzatal, Schiltach, Schneverdingen, Schwäbisch Hall, Schwetzingen, Siegen, Sinsheim, Stadtroda, Stuttgart, Tirschenreuth, Trier, Tübingen, Unterhaching, Untermeitingen, Velbert, Weil der Stadt, Wildeshausen, Wolfratshausen
- Életkor
- 18 év to 100 év
- People
- 800
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05344469 - No phaseTaking peopleCognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis
- Where
- Düsseldorf, Mönchengladbach
- Életkor
- 18 év to 79 év
- People
- 837
- Run by
- Heinrich-Heine University, Duesseldorf
See details and how to joinNCT07426991 - 2/3. fázisTaking peopleA Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
- Where
- Berlin, Bochum, Hamburg, Hanover
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Kyverna Therapeutics
See details and how to joinNCT07403188 · EU 2024-511198-31-00 - No phaseTaking peopleClinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
- Where
- Berlin, Bochum
- Életkor
- 18 év and over
- People
- 7000 worldwide
- Run by
- icometrix
See details and how to joinNCT06280755 - No phaseTaking peopleA Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
- Where
- Herne
- People
- 1182 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05170126 - No phaseCsak meghívásosKappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)
- Where
- Hanover
- Életkor
- 18 év to 70 év
- People
- 1142
- Run by
- Skripuletz, Thomas Prof. Dr.
See details and how to joinNCT07183020 - No phaseTaking peopleUnderstanding the 'Durable Effect' Concept of B-cell Modulating Therapies
- Where
- Düsseldorf
- Életkor
- 18 év to 60 év
- People
- 100
- Run by
- Heinrich-Heine University, Duesseldorf
See details and how to joinNCT06586177 - No phaseTaking peopleSmart Monitoring Assessing Spasticity-related Health
- Where
- Düsseldorf
- Életkor
- 18 év and over
- People
- 46
- Run by
- Heinrich-Heine University, Duesseldorf
See details and how to joinNCT06937723 - No phaseTaking peopleMeasuring Silent Disease Progression in Multiple Sclerosis With a Multimodal Approach
- Where
- Düsseldorf
- Életkor
- 18 év and over
- People
- 77
- Run by
- Heinrich-Heine University, Duesseldorf
See details and how to joinNCT06501950 - No phaseTaking peoplePregnancy Cohort in Multiple Sclerosis (MS)
- Where
- Berlin
- Életkor
- 18 év to 50 év
- People
- 100
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT05010902 - No phaseTaking peopleStrategies for Adaptive Follow-up and Evaluation - Guiding Use of Indicators for De-Escalation in Multiple Sclerosis
- Where
- Düsseldorf
- Életkor
- 18 év and over
- People
- 150
- Run by
- Heinrich-Heine University, Duesseldorf
See details and how to joinNCT06461481